Specify a stock or a cryptocurrency in the search bar to get a summary
Q linea AB
QLINEAQ-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in the United Kingdom. The company offers ASTar, an antibiotic susceptibility testing system used for positive blood cultures; and in vitro diagnostics systems for infectious diseases. It serves healthcare providers. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden. Address: Dag HammarskjOelds vAeg 52 A, Uppsala, Sweden, 752 37
Analytics
WallStreet Target Price
32.95 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures QLINEA
Dividend Analytics QLINEA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QLINEA
Stock Valuation QLINEA
Financials QLINEA
Results | 2019 | Dynamics |